Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Users Online: 48

 

Home  | About Us | Editors | Search | Ahead Of Print | Current Issue | Archives | Submit Article | Instructions | Subscribe | Contacts | Login 
     
  Feedback 
  Subscribe 
 Back To Article

  Reader Comments

Year : 2021 | Volume:  11 | Issue Number:  3

EDITORIAL

What's new in critical illness and injury science? An evidence-based analysis of the impact of Janus Kinase inhibitors on 28-day mortality in patients admitted with COVID-19

Miller Andrew C, D'Silva Yannick A

Add Your Comments
 
No one has added comments on this article. Click here to add your remarks